Versa Vascular, Inc.
PrivateLast Round
Series C
Aug 11, 2026
Est. Valuation
$96M
Total Funding Raised
$69.3M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Versa Vascular, Inc. is a medical technology company that develops minimally invasive catheter-based implant systems to treat tricuspid valve regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Versa Vascular, Inc. Comparables
Compare Versa Vascular, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CroíValve | 89% | |
| VDyne | 88% | |
| Laplace Interventional | 85% |
Versa Vascular, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 11, 2026 | ||||
| Series C | Jul 28, 2025 |
Versa Vascular, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cadence Healthcare Ventures | Series C |
| View Ventures | Series C |
| Santa Cruz Ventures | Series C |
| BioStar Capital | Series C |
| S3 Ventures | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 11, 2026
$42M round led by BioStar Capital and S3 Ventures.
- Jan 25, 2026
Grew 19% QoQ, from 16 to 19 employees.
Recent news
Latest coverage and updates
- receives_financingAug 13, 2026
Versa Vascular receives financing of $42.3M in Series C.
- hiresAug 13, 2026
Versa Vascular hired Bill Shields as CEO on Aug 13th '26.
Versa Vascular, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Versa Vascular, Inc.'s valuation, stock price, and market status.
Is Versa Vascular, Inc. a public or private company?
Versa Vascular, Inc. is a private company.
What is the current stock price of Versa Vascular, Inc.?
Versa Vascular, Inc. is a private company with no public stock price. Caplight tracks Versa Vascular, Inc.'s secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Versa Vascular, Inc. worth (valuation)?
Versa Vascular, Inc.'s valuation is estimated at $96.0M based on funding round data.
Can I buy Versa Vascular, Inc. stock?
Versa Vascular, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Versa Vascular, Inc.'s last funding round?
Versa Vascular, Inc.'s most recent funding round was Series C on July 28, 2025.
Who are the main investors in Versa Vascular, Inc.?
Key investors in Versa Vascular, Inc. include S3 Ventures.
Will Versa Vascular, Inc. IPO soon?
No public IPO plans have been announced for Versa Vascular, Inc..
How can I track Versa Vascular, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Versa Vascular, Inc.'s secondary market activity and sign up for updates.